Skip to main content
Erschienen in: Clinical and Translational Oncology 1/2020

30.10.2019 | Research Article

MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis

verfasst von: H. Q. Mu, Y. H. He, S. B. Wang, S. Yang, Y. J. Wang, C. J. Nan, Y. F. Bao, Q. P. Xie, Y. H. Chen

Erschienen in: Clinical and Translational Oncology | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Angiogenesis is a critical biological process essential for solid cancer growth and metastasis. It has been shown that microRNAs (miRNAs) play a vital role in a variety of biological processes in cancers. However, whether miR-130b is involved in prostate cancer angiogenesis remains ill-defined.

Methods

We performed the miRNA microarray to analyze miRNA expression in human prostate cancer specimens. In vitro gain-of-function assays and loss-of-function assays were conducted to explore the potential functions of miR-130b in human prostate cancer cells. Correlation analysis and dual-luciferase reporter assay were performed to validate whether tumor necrosis factor-α (TNF-α) was a direct target of miR-130b. The Matrigel plug and tumor vascular imaging assays were performed to confirm the anti-angiogenic activity of miR-130b in nude mice.

Results

We found that miR-130b was one of the miRNAs being most significantly downregulated. Subsequently, we found that miR-130b expression was markedly downregulated in human prostate cancer cell lines. Down-regulation of miR-130b in prostate cancer cells significantly promoted the proliferation, invasion and tubule formation of human umbilical vein endothelial cells (HUVECs), while ectopic expression of miR-130b blocked prostate cancer angiogenesis in vitro and in vivo. Mechanistic analyses indicated that tumor necrosis factor-α (TNF-α) was regulated by miR-130b directly. MiR-130b attenuated nuclear factor-κB (NF-κB) signaling and its downstream gene vascular endothelial growth factor-A (VEGFA) by directly inhibiting TNF-α expression. Additionally, subsequent investigations identified that the ectopic level of VEGFA markedly abrogated the anti-angiogenic effect induced by miR-130b. Interestingly, VEGFA could in turn decrease the expression of miR-130b, thus forming a negative feedback loop that drives the angiogenesis of prostate cancer.

Conclusion

These findings show that miR-130b/TNF-α/NF-κB/VEGFA feedback loop is significantly correlated with angiogenesis in prostate cancer and miR-130b could be regarded as potential therapeutic target for prostate cancer anti-angiogenesis treatment.
Literatur
1.
Zurück zum Zitat Scher HI, Solo K, Valant J, et al. Prevalence of prostate cancer clinical states and mortality in the United States: estimates using a dynamic progression model. PLoS One. 2015;10(10):e0139440.PubMedPubMedCentralCrossRef Scher HI, Solo K, Valant J, et al. Prevalence of prostate cancer clinical states and mortality in the United States: estimates using a dynamic progression model. PLoS One. 2015;10(10):e0139440.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Owens OL, Jackson DD, Thomas TL, et al. Prostate cancer knowledge and decision making among African-American men and women in the Southeastern United States. Int J Men’s Health. 2015;14(1):55–70. Owens OL, Jackson DD, Thomas TL, et al. Prostate cancer knowledge and decision making among African-American men and women in the Southeastern United States. Int J Men’s Health. 2015;14(1):55–70.
3.
Zurück zum Zitat Pellegrini KL, Sanda MG, Patil D, et al. Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality. BJUI. 2017;119(6):961–7.CrossRef Pellegrini KL, Sanda MG, Patil D, et al. Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality. BJUI. 2017;119(6):961–7.CrossRef
4.
Zurück zum Zitat Rycaj K, Li H, Zhou J, et al. Cellular determinants and microenvironmental regulation of prostate cancer metastasis. Semin Cancer Biol. 2017;44:83–97.PubMedPubMedCentralCrossRef Rycaj K, Li H, Zhou J, et al. Cellular determinants and microenvironmental regulation of prostate cancer metastasis. Semin Cancer Biol. 2017;44:83–97.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Ci X, Xing C, Zhang B, et al. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation. Mol Cancer. 2015;14:91.PubMedPubMedCentralCrossRef Ci X, Xing C, Zhang B, et al. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation. Mol Cancer. 2015;14:91.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Khanmi K, Ignacimuthu S, Paulraj MG, et al. MicroRNA in prostate cancer. Clin Chim Acta. 2015;451:154–60.PubMedCrossRef Khanmi K, Ignacimuthu S, Paulraj MG, et al. MicroRNA in prostate cancer. Clin Chim Acta. 2015;451:154–60.PubMedCrossRef
8.
Zurück zum Zitat Li Q, Lu S, Li X, et al. Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2. Clin Transl Oncol. 2017;19(5):562–70.PubMedCrossRef Li Q, Lu S, Li X, et al. Biological function and mechanism of miR-33a in prostate cancer survival and metastasis: via downregulating Engrailed-2. Clin Transl Oncol. 2017;19(5):562–70.PubMedCrossRef
9.
Zurück zum Zitat Du Z, Sun T, Hacisuleyman E, et al. Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun. 2016;7:10982–10982.PubMedPubMedCentralCrossRef Du Z, Sun T, Hacisuleyman E, et al. Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun. 2016;7:10982–10982.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Liu A, Hou C, Chen H, et al. Genetics and epigenetics of glioblastoma: applications and overall incidence of IDH1 mutation. Front Oncol. 2016;6:16.PubMedPubMedCentral Liu A, Hou C, Chen H, et al. Genetics and epigenetics of glioblastoma: applications and overall incidence of IDH1 mutation. Front Oncol. 2016;6:16.PubMedPubMedCentral
12.
Zurück zum Zitat Shahjahani M, Khodadi E, Seghatoleslami M, et al. Rare cytogenetic abnormalities and alteration of microRNAs in acute myeloid leukemia and response to therapy. Oncol Rev. 2015;9(1):261.PubMedPubMedCentralCrossRef Shahjahani M, Khodadi E, Seghatoleslami M, et al. Rare cytogenetic abnormalities and alteration of microRNAs in acute myeloid leukemia and response to therapy. Oncol Rev. 2015;9(1):261.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Dong P, Karaayvaz M, Jia N, et al. Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene. 2013;32(27):3286–95.PubMedCrossRef Dong P, Karaayvaz M, Jia N, et al. Mutant p53 gain-of-function induces epithelial–mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene. 2013;32(27):3286–95.PubMedCrossRef
14.
Zurück zum Zitat Yip L, Kelly L, Shuai Y, et al. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann Surg Oncol. 2011;18(7):2035–41.PubMedCrossRef Yip L, Kelly L, Shuai Y, et al. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann Surg Oncol. 2011;18(7):2035–41.PubMedCrossRef
15.
Zurück zum Zitat Zhao G, Zhang JG, Shi Y, et al. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3. PLoS One. 2013;8(9):e73803.PubMedPubMedCentralCrossRef Zhao G, Zhang JG, Shi Y, et al. MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3. PLoS One. 2013;8(9):e73803.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Zhao Yanyang, Miao Gang, Li Yao, et al. MicroRNA-130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1. PLoS One. 2014;9(2):e87938.PubMedPubMedCentralCrossRef Zhao Yanyang, Miao Gang, Li Yao, et al. MicroRNA-130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1. PLoS One. 2014;9(2):e87938.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Duan J, Zhang H, Qu Y, et al. Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer. Oncotarget. 2016;7(28):44522–33.PubMedPubMedCentralCrossRef Duan J, Zhang H, Qu Y, et al. Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer. Oncotarget. 2016;7(28):44522–33.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Li S, Geng J, Xu X, et al. miR-130b-3p modulates epithelial–mesenchymal crosstalk in lung fibrosis by targeting IGF-1. PLoS One. 2016;11(3):e0150418.PubMedPubMedCentralCrossRef Li S, Geng J, Xu X, et al. miR-130b-3p modulates epithelial–mesenchymal crosstalk in lung fibrosis by targeting IGF-1. PLoS One. 2016;11(3):e0150418.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Chen Q, Zhao X, Zhang H, et al. MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2. Mol Carcinog. 2015;54(11):1292–300.PubMedCrossRef Chen Q, Zhao X, Zhang H, et al. MiR-130b suppresses prostate cancer metastasis through down-regulation of MMP2. Mol Carcinog. 2015;54(11):1292–300.PubMedCrossRef
20.
Zurück zum Zitat Sun Y, Jia X, Hou L, Liu X. Screening of differently expressed miRNA and mRNA in prostate cancer by integrated analysis of transcription data. Urology. 2016;94(313):e1–6. Sun Y, Jia X, Hou L, Liu X. Screening of differently expressed miRNA and mRNA in prostate cancer by integrated analysis of transcription data. Urology. 2016;94(313):e1–6.
21.
Zurück zum Zitat Ramalhocarvalho J, Graca I, Gomez A, et al. Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer. J Hematol Oncol. 2017;10:1–43.CrossRef Ramalhocarvalho J, Graca I, Gomez A, et al. Downregulation of miR-130b~301b cluster is mediated by aberrant promoter methylation and impairs cellular senescence in prostate cancer. J Hematol Oncol. 2017;10:1–43.CrossRef
22.
Zurück zum Zitat Lin J, Cao S, Wang Y, et al. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma. J Exp Clin Cancer Res. 2018;37(1):113.PubMedPubMedCentralCrossRef Lin J, Cao S, Wang Y, et al. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma. J Exp Clin Cancer Res. 2018;37(1):113.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Xu S, Bai J, Zhuan Z, et al. EBV–LMP1 is involved in vasculogenic mimicry formation via VEGFA/VEGFR1 signaling in nasopharyngeal carcinoma. Oncol Rep. 2018;40(1):377–84.PubMed Xu S, Bai J, Zhuan Z, et al. EBV–LMP1 is involved in vasculogenic mimicry formation via VEGFA/VEGFR1 signaling in nasopharyngeal carcinoma. Oncol Rep. 2018;40(1):377–84.PubMed
24.
Zurück zum Zitat Cui J, Gong C, Cao B, et al. MicroRNA-27a participates in the pathological process of depression in rats by regulating VEGFA. Exp Ther Med. 2018;15(5):4349–55.PubMedPubMedCentral Cui J, Gong C, Cao B, et al. MicroRNA-27a participates in the pathological process of depression in rats by regulating VEGFA. Exp Ther Med. 2018;15(5):4349–55.PubMedPubMedCentral
25.
Zurück zum Zitat Thawan R, Thomas A, Thakur K. Tracheomediastinal fistula: rare complication of treatment with bevacizumab. Cureus. 2018;10(4):e2419. Thawan R, Thomas A, Thakur K. Tracheomediastinal fistula: rare complication of treatment with bevacizumab. Cureus. 2018;10(4):e2419.
26.
Zurück zum Zitat Ham B, Fernandez MC, D'Costa Z, et al. The diverse roles of the TNF axis in cancer progression and metastasis. Trends Cancer Res. 2016;11(1):1–27.PubMedPubMedCentral Ham B, Fernandez MC, D'Costa Z, et al. The diverse roles of the TNF axis in cancer progression and metastasis. Trends Cancer Res. 2016;11(1):1–27.PubMedPubMedCentral
27.
Zurück zum Zitat Luo W, Tweedie D, Beedie SL, et al. Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-α and angiogenesis inhibitory activities. Bioorg Med Chem. 2018;26(8):1547–59.PubMedPubMedCentralCrossRef Luo W, Tweedie D, Beedie SL, et al. Design, synthesis and biological assessment of N-adamantyl, substituted adamantyl and noradamantyl phthalimidines for nitrite, TNF-α and angiogenesis inhibitory activities. Bioorg Med Chem. 2018;26(8):1547–59.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Sun H, Zhu X, Zhou Y, et al. C1q/TNF-related protein-9 ameliorates Ox-LDL-induced endothelial dysfunction via PGC-1α/AMPK-mediated antioxidant enzyme induction. Int J Mol Sci. 2017;18(6):E1097.PubMedCrossRef Sun H, Zhu X, Zhou Y, et al. C1q/TNF-related protein-9 ameliorates Ox-LDL-induced endothelial dysfunction via PGC-1α/AMPK-mediated antioxidant enzyme induction. Int J Mol Sci. 2017;18(6):E1097.PubMedCrossRef
29.
Zurück zum Zitat Tang N, Ma J, Wang KS, et al. Dihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression. Mol Cell Biochem. 2016;422(1–2):11–20.PubMedCrossRef Tang N, Ma J, Wang KS, et al. Dihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression. Mol Cell Biochem. 2016;422(1–2):11–20.PubMedCrossRef
30.
Zurück zum Zitat Li J, Ma J, Wang KS, et al. Baicalein inhibits TNF-α-induced NF-κB activation and expression of NF-κB-regulated target gene products. Oncol Rep. 2016;36(5):2771–6.PubMedCrossRef Li J, Ma J, Wang KS, et al. Baicalein inhibits TNF-α-induced NF-κB activation and expression of NF-κB-regulated target gene products. Oncol Rep. 2016;36(5):2771–6.PubMedCrossRef
Metadaten
Titel
MiR-130b/TNF-α/NF-κB/VEGFA loop inhibits prostate cancer angiogenesis
verfasst von
H. Q. Mu
Y. H. He
S. B. Wang
S. Yang
Y. J. Wang
C. J. Nan
Y. F. Bao
Q. P. Xie
Y. H. Chen
Publikationsdatum
30.10.2019
Verlag
Springer International Publishing
Erschienen in
Clinical and Translational Oncology / Ausgabe 1/2020
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-019-02217-5

Weitere Artikel der Ausgabe 1/2020

Clinical and Translational Oncology 1/2020 Zur Ausgabe

ACKNOWLEDGEMENT TO REVIEWERS

Thanks to reviewers 2019

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.